enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Rimegepant - Wikipedia

    en.wikipedia.org/wiki/Rimegepant

    Rimegepant, sold under the brand name Nurtec ODT among others, is a medication used for the acute treatment of migraine with or without aura in adults and the prophylactic/ preventive treatment of episodic migraine in adults.

  3. Calcitonin gene-related peptide receptor antagonist - Wikipedia

    en.wikipedia.org/wiki/Calcitonin_gene-related...

    [1] Several monoclonal antibodies that bind to the CGRP receptor or peptide have been approved for prevention of migraine. [2] Nerve activation triggers the release of CGRP and other neuropeptides, leading to inflammation, pain, and swelling. Three small molecule CGRPR antagonists are approved in the U.S. as antimigraine agents.

  4. Prevention of dementia - Wikipedia

    en.wikipedia.org/wiki/Prevention_of_dementia

    The prevention of dementia involves reducing the number of risk factors for the development of dementia, and is a global health priority needing a global response. [1] [2] Initiatives include the establishment of the International Research Network on Dementia Prevention (IRNDP) [3] which aims to link researchers in this field globally, and the establishment of the Global Dementia Observatory ...

  5. Biohaven's (BHVN) Nurtec Gets FDA Nod for Migraine Prevention

    www.aol.com/news/biohavens-bhvn-nurtec-gets-fda...

    For premium support please call: 800-290-4726 more ways to reach us

  6. Anti-amyloid drugs - Wikipedia

    en.wikipedia.org/wiki/Anti-amyloid_drugs

    Aducanumab, sold under the brand name Aduhelm, is an anti-amyloid drug designed to treat Alzheimer's disease. It is a monoclonal antibody that targets aggregated forms (plaque) of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. [10] It was developed by Biogen and Eisai. [11] Aducanumab is given via intravenous infusion. [5] Aducanumab was ...

  7. Template:Anti-dementia drugs - Wikipedia

    en.wikipedia.org/wiki/Template:Anti-dementia_drugs

    To change this template's initial visibility, the |state= parameter may be used: {{Anti-dementia drugs | state = collapsed}} will show the template collapsed, i.e. hidden apart from its title bar. {{Anti-dementia drugs | state = expanded}} will show the template expanded, i.e. fully visible.

  8. About 4% of US adults age 65 and older have a dementia ...

    www.aol.com/news/4-us-adults-age-65-040225251.html

    The CDC said 1.7% of adults ages 65 to 74 reported a dementia diagnosis, a rate that increased with age. For those ages 75 to 84, the reported dementia rate was 5.7%

  9. How a new FDA-approved drug can — and can’t — help people ...

    www.aol.com/fda-approved-drug-t-help-121600044.html

    Leqembi’s approval made headlines, and for good reason. More than 6 million Americans live with Alzheimer’s. And 1 in 3 adults ages 65 and older dies with it or another form of dementia ...